Dr. Andrea Schietinger is an Assistant Member in the Immunology Program at Memorial Sloan Kettering Cancer Center (MSKCC), and Assistant Professor at Weill Cornell Medical College in New York. Her laboratory studies the molecular and epigenetic mechanisms underlying T cell differentiation and dysfunction in the context of self-tolerance, autoimmunity and tumors. After receiving her degree in Pharmacology from the University of Hamburg, she enrolled in a joint PhD program between the Ludwig Maximilian University of Munich (LMU) and The University of Chicago (UofC). During her PhD she worked in Dr. Hans Schreiber’s laboratory at the UofC, where she studied how aberrant posttranslational glycosylation of wildtype proteins in cancer cells creates tumor-specific neo-antigens; she received her PhD in 2007 from the LMU. As a postdoctoral fellow in Dr. Philip Greenberg’s lab at the University of Washington in Seattle, she investigated the transcriptional programs needed for self-reactive T cells to maintain peripheral self-tolerance.